Microbix Biosystems Inc T.MBX

Alternate Symbol(s): MBXBF

Healthcare Biotechnology

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.

TSX:MBX - Post by User

Microbix Biosystems Inc > Analysis

<< Previous

Bullboard Posts

Next >>

Comment by RICHOFFMBXon Jun 10, 2024 5:43pm

133 Views

Post# 36081718

RE:RE:RE:RE:RE:Analysis

Agreed. Some good news is that there's been more volume on the buy side of things for the last few weeks. Nobody seems to be jumping at the bid still - a lot of patience and restraint, but a marked improvement over the last 2 months for the time being, at least.

<< Previous

Bullboard Posts

Next >>

The top TSX healthcare stocks under $1